Equities
  • Price (USD)62.27
  • Today's Change-0.62 / -0.99%
  • Shares traded23.03k
  • 1 Year change+58.93%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 21:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LONN:SWX since
announced
Transaction
value
Genentech Inc-Biologics Manufacturing Facility,Vacaville,CaliforniaDeal completed20 Mar 202420 Mar 2024Deal completed15.89%1.20bn
Data delayed at least 15 minutes, as of Nov 14 2024 16:34 GMT.

Institutional shareholders

0.53%Per cent of shares held by top holders
HolderShares% Held
SBI Funds Management Ltd.as of 31 Oct 20243.01m0.42%
Manning & Napier Advisors LLCas of 30 Sep 2024249.31k0.04%
Strategic Advisers LLCas of 31 Jul 2024190.06k0.03%
Zevin Asset Management LLCas of 30 Sep 2024124.83k0.02%
Torray Investment Partners LLCas of 30 Sep 2024108.40k0.02%
Madison Asset Management LLCas of 30 Jun 202457.16k0.01%
Invesco Advisers, Inc.as of 30 Sep 202442.47k0.01%
Domini Impact Investments LLCas of 31 Jul 202425.50k0.00%
RhumbLine Advisers LPas of 30 Jun 202413.50k0.00%
Causeway Capital Management LLCas of 03 Oct 202412.41k0.00%
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.